Circulating markers of liver function and cardiovascular disease risk

Circulating markers of liver function and cardiovascular disease risk

Bibliographic Details
Main Authors:	Targher, Giovanni (Author), Byrne, Christopher D. (Author)
Format:	Article
Language:	English
Published:	2015-11.
Subjects:	Article
Online Access:	Get fulltext

Similar Items

Time to replace assessment of liver histology with MR-based imaging tests to assess efficacy of interventions for nonalcoholic fatty liver disease
by: Byrne, Christopher D., et al.
Published: (2015)

Gallstone disease and increased risk of ischemic heart disease: causal association or epiphenomenon?
by: Targher, G., et al.
Published: (2015)

NAFLD: A multisystem disease
by: Byrne, Christopher D., et al.
Published: (2015)

What’s Past Is Prologue: History of Nonalcoholic Fatty Liver Disease
by: Giovanni Targher
Published: (2020-10-01)

EASL-EASD-EASO Clinical practice guidelines for the management of nonalcoholic fatty liver disease: is universal screening appropriate?
by: Byrne, C., et al.
Published: (2016)

Role of circulating oxidized LDL: a useful diagnostic risk marker in cardiovascular disease
by: Deepti Mandsorwale, et al.
Published: (2021-05-01)

Circulating cell-derived microparticles : potential markers of cardiovascular risk
by: Ayers, Lisa
Published: (2012)

Non-invasive fibrosis assessment in non-alcoholic fatty liver disease
by: Rafael S. Rios, et al.
Published: (2020-11-01)

Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease
by: Yuen-Kwun Wong, et al.
Published: (2021-10-01)

Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease
by: Stefano Ballestri, et al.
Published: (2021-01-01)

Renal function and markers of cardiovascular risk
by: Kastarinen, H. (Helena)
Published: (2010)

Proteomic, circulating and functional biomarkers of cardiovascular disease
by: Neisius, Ulf
Published: (2013)

Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers
by: Sohan Punia, et al.
Published: (2021-04-01)

Inflammatory markers and cardiovascular disease
by: Hammett, Christopher John Keith
Published: (2012)

Circulating Extracellular RNA Markers of Liver Regeneration.
by: Irene K Yan, et al.
Published: (2016-01-01)

Inflammatory markers, endothelial function and cardiovascular risk
by: Bruno Costa Teixeira, et al.
Published: (2014-04-01)

Leptin : a risk marker for cardiovascular disease
by: Söderberg, Stefan
Published: (1999)

Liver function markers predict cardiovascular and renal outcomes in the CANVAS Program
by: Ferrannini, E., et al.
Published: (2022)

Circulating angiopoietin-2 is a marker for early cardiovascular disease in children on chronic dialysis.
by: Rukshana C Shroff, et al.
Published: (2013-01-01)

Synergy of circulating miR-212 with markers for cardiovascular risks to enhance estimation of atherosclerosis presence.
by: Hye Seon Jeong, et al.
Published: (2017-01-01)

Circulating Biomarkers in Cardiovascular Disease
by: Erik Ingelsson
Published: (2009-01-01)

Human and molecular genetics shed lights on fatty liver disease and diabetes conundrum
by: Federica Tavaglione, et al.
Published: (2020-10-01)

Epidemiological modifiers of non-alcoholic fatty liver disease: focus on high-risk groups
by: Lonardo, A., et al.
Published: (2015)

Correction: Synergy of circulating miR-212 with markers for cardiovascular risks to enhance estimation of atherosclerosis presence.
by: PLOS ONE Staff
Published: (2017-01-01)

Dysregulated Neurovascular Control Underlies Declining Microvascular Functionality in People With Non-alcoholic Fatty Liver Disease (NAFLD) at Risk of Liver Fibrosis
by: Geraldine F. Clough, et al.
Published: (2020-06-01)

Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
by: Alessandro Mantovani, et al.
Published: (2016-02-01)

Relationship between dietary intake, endothelial function, adipokines and other markers of cardiovascular disease risk
by: McCourt, Hannah Judith
Published: (2011)

Role of cardiovascular disease markers in periodontal infection: Understanding the risk
by: Mili Gupta, et al.
Published: (2015-01-01)

Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis—Literature Review
by: Abdulrahman Ismaiel, et al.
Published: (2019-09-01)

Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus.
by: Alessandro Mantovani, et al.
Published: (2017-01-01)

Marine Carotenoids and Cardiovascular Risk Markers
by: Lorenza Speranza, et al.
Published: (2011-06-01)

Cardiovascular system status of long-livers in Moscow: the prevalence of cardiovascular diseases and their risk factors
by: K. A. Eruslanova, et al.
Published: (2021-04-01)

Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease
by: Arvind, A., et al.
Published: (2022)

Early Markers of Cardiovascular Risk in Autosomal Dominant Polycystic Kidney Disease
by: Silvia Lai, et al.
Published: (2017-12-01)

Implications of Diet in Cardiovascular Disease Risk: Postprandial Changes in Circulating Monocytes and Endotoxemia
by: Venable, Andrea Henning
Published: (2018)

Biological markers in risk stratification and progression of cardiovascular disease: present and future
by: V. L. Ostanko, et al.
Published: (2018-12-01)

Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure.
by: Filippo Valbusa, et al.
Published: (2017-01-01)

Haptoglobin Genotype and Risk Markers of Cardiovascular Disease in Patients with Chronic Kidney Disease
by: Charlotte Strandhave, et al.
Published: (2013-01-01)

Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes.
by: Giovanni Targher, et al.
Published: (2013-01-01)

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight
by: Stefano Ballestri, et al.
Published: (2016-03-01)

Cannot write session to /tmp/vufind_sessions/sess_et0fj5j696qtueefo16nkrtimu